🔎 Trials Near Me

Inicio › Obesidad › Wisconsin

Ensayos clínicos de Obesidad en Wisconsin

11 estudios sobre Obesidad buscan participantes en Wisconsin.

Ciudades en Wisconsin

Texto oficial del estudio (inglés)

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Ascension Columbia St. Mary's, Milwaukee
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351045

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Wisconsin Center for Advanced Research, Milwaukee
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Wisconsin Center for Advanced Research, Milwaukee
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086

Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)

  • Fortrea Clinical Research Unit Inc. - Madison, Madison
ReclutandoFase 1
Edades de 18 a 70 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07908316

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Advocate Aurora Saint Lukes Medical Center, Milwaukee
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 29 oct 2026 · NCT07037459

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Allegiance Research Specialists, Wauwatosa
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07684235

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  • Prevea Health, Green Bay
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07564414

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Marshfield Clinic, Marshfield
  • Aurora St. Luke's Medi Ctr, Milwaukee
  • Cardio Research & Education Foundation, Wausau
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07567001

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT06106477

Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity

  • Advocate Aurora Research Institute, Milwaukee
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 jun 2026 · NCT07227051

Stand up for Your Health With a Sit-stand Desk

  • Medical College of Wisconsin, Milwaukee
Reclutando
Edades de 18 a 79 · Todos los sexos · Actualizado el 4 may 2026 · NCT05585190

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.